Recently, testing of treatments known as cellular therapies, often called “CAR-T,” has shown promise beyond the medications ...
Lupus nephritis occurs in approximately half of patients diagnosed with systemic lupus erythematosus. One in 10 patients with ...
MedPage Today on MSN
GLP-1 Drugs Show Benefits in Lupus Patients With Diabetes
Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk ...
Systemic lupus erythematosus is a clinically and immunologically heterogenous, systemic autoimmune disease characterized by ...
In June 2024, Nkarta announced the initiation of Ntrust-I, a multi-center clinical trial of NKX019 in lupus nephritis, with ...
Mental health: Lupus causes issues with mental health and thinking, due to a cognitive impairment commonly known as “brain ...
Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Speakers Dr. Daniel Clauw and ...
MedPage Today on MSN
Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus
Clinical results were spottier. Chen and colleagues tracked SLE Disease Activity Index (SLEDAI) values from pretreatment ...
Complete, but not partial, remission was associated with a lower likelihood of doubling of serum creatinine in patients with pure membranous lupus nephritis.
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michael S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results